(PharmaNewsWire.Com, May 02, 2017 ) According to the report Europe Uterine Cancer Therapeutics Market, published by Market Data Forecast, the European market is projected to reach USD 6996.1 million by 2021, at a CAGR of 5.34% from 2016 to 2021.
The uterus is a hollow organ in females situated in the pelvis, usually called the womb. The uterus capacities to bolster fetal improvement until birth. Abnormal growth of cells that comprises Uterus tissue causes uterine cancer.
Uterine Cancer can be treated using Surgery, Immunotherapy, Radiotherapy, Chemotherapy and hormone therapy. Radiotherapy is use of high energy radiation to destroy cancer cells while chemotherapy is use of drugs to kill Cancer cells. Hormone therapy is used to slow down the growth of cancer cells.
Uterine Cancer is the sixth most common cancer in woman. It is more prevalent in developed Countries than others. 5-year Survival rate is higher in Europe because of its high income.
Advancements in technology to develop innovative cancer therapy solutions, increasing number of newly diagnosed uterine cancer cases, and rising government support to develop effective therapeutics are driving the growth of Uterine Cancer Therapeutics Market in Europe. However, improper reimbursement policies and stringent regulations are expected to restrain the growth of Uterine Cancer Therapeutics Market in Europe.
Segmentation:
By Type • Endometrial Carcinoma a) Adenocarcinoma b) Carcinosarcoma c) Squamous cell carcinoma d) Others • Uterine Sarcoma
By Therapy • Surgery • Chemotherapy • Radiation Therapy • Immunotherapy • Hormone Therapy
Abbott Laboratories, Ariad Pharmaceuticals, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis AG, Sanofi, Siemens Healthcare GmbH, and Takeda Pharmaceutical Company Ltd are the key players in this market.
The Europe Uterine Cancer Therapeutics Market Study covers:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Check out other related studies in the Therapeutics Segment:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
